Medifast Inc
NYSE:MED
Medifast Inc
Cash & Cash Equivalents
Medifast Inc
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medifast Inc
NYSE:MED
|
Cash & Cash Equivalents
$90.9m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
14%
|
|
|
Estee Lauder Companies Inc
NYSE:EL
|
Cash & Cash Equivalents
$2.6B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
8%
|
|
|
Bellring Brands Inc
NYSE:BRBR
|
Cash & Cash Equivalents
$49.6m
|
CAGR 3-Years
18%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Coty Inc
NYSE:COTY
|
Cash & Cash Equivalents
$249.6m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-15%
|
|
|
Inter Parfums Inc
NASDAQ:IPAR
|
Cash & Cash Equivalents
$125.4m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
3%
|
|
|
elf Beauty Inc
NYSE:ELF
|
Cash & Cash Equivalents
$73.8m
|
CAGR 3-Years
31%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
Medifast Inc
Glance View
Medifast, Inc. engages in the provision of healthy living products and programs. The company is headquartered in Owings Mills, Maryland and currently employs 984 full-time employees. The firm's operations are conducted through its subsidiaries Jason Pharmaceuticals, Inc., OPTAVIA, LLC, Jason Enterprises, Inc., Jason Properties, LLC, Medifast Franchise Systems, Inc., Seven Crondall Associates, LLC, Corporate Events, Inc., OPTAVIA (Hong Kong) Limited, OPTAVIA (Singapore) PTE. LTD and OPTAVIA Health Consultation (Shanghai) Co., Ltd. The firm's product line includes approximately 137 consumable options, including, bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. The Company, through Medifast Direct, its direct-to-consumer business unit.
See Also
What is Medifast Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
90.9m
USD
Based on the financial report for Dec 31, 2024, Medifast Inc's Cash & Cash Equivalents amounts to 90.9m USD.
What is Medifast Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
14%
Over the last year, the Cash & Cash Equivalents growth was -4%. The average annual Cash & Cash Equivalents growth rates for Medifast Inc have been -4% over the past three years , 3% over the past five years , and 14% over the past ten years .
You don't have any saved screeners yet